A Randomized, Double-Blind, Double-Dummy Study to Evaluate the Intranasal Human Abuse Potential and Pharmacokinetics of a Novel Extended-Release Abuse-Deterrent Formulation of Oxycodone

Objective. Evaluate the human abuse potential (HAP) of an experimental, microsphere-in-capsule formulation of extended-release oxycodone (oxycodone DETERx®) (herein “DETERx”). Design. Randomized, double-blind, double-dummy, positive- and placebo-controlled, single-dose, four-phase, four-treatment, c...

Descripción completa

Detalles Bibliográficos
Autores principales: Webster, Lynn R., Kopecky, Ernest A., Smith, Michael D., Fleming, Alison B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
OPIOIDS, SUBSTANCE ABUSE & ADDICTIONS SECTION
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894244/
https://www.ncbi.nlm.nih.gov/pubmed/26814256
http://dx.doi.org/10.1093/pm/pnv020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894244/
https://www.ncbi.nlm.nih.gov/pubmed/26814256
http://dx.doi.org/10.1093/pm/pnv020

Ejemplares similares